(Total Views: 139)
Posted On: 11/29/2023 3:41:31 PM
Post# of 107025
$NBIO - Nascent Biotech Granted Japanese Patent for Crossing Blood-Brain Barrier.
The patent allowance recognizes PTB's ability to act as a monotherapy, as well as its potential to act as a conjugate, bringing other therapies across the BBB.
https://finance.yahoo.com/news/nascent-biotec...00461.html
The patent allowance recognizes PTB's ability to act as a monotherapy, as well as its potential to act as a conjugate, bringing other therapies across the BBB.
https://finance.yahoo.com/news/nascent-biotec...00461.html
(0)
(0)
